# Efalizumab to Treat Uveitis

> **NCT00280826** · PHASE1 · COMPLETED · sponsor: **National Eye Institute (NEI)** · enrollment: 6 (actual)

## Conditions studied

- Uveitis
- Macular Edema

## Interventions

- **DRUG:** Efalizumab

## Key facts

- **NCT ID:** NCT00280826
- **Lead sponsor:** National Eye Institute (NEI)
- **Sponsor class:** NIH
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-01
- **Primary completion:** 2009-02
- **Final completion:** 2009-02
- **Target enrollment:** 6 (ACTUAL)
- **Last updated:** 2011-02-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00280826

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00280826, "Efalizumab to Treat Uveitis". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00280826. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*